Edwards Lifesciences (EW) Interest Expenses (2009 - 2017)

Edwards Lifesciences (EW) recorded quarterly Interest Expenses of $19.3 million in Q4 2017, up 19200.0% quarter-over-quarter from $100000.0 in Q3 2017, and up 56.91% on a YoY basis from $12.3 million in Q4 2016.

Edwards Lifesciences (EW) Interest Expenses (2009 - 2017) Analysis & Trends

Edwards Lifesciences' Interest Expenses history runs 4 years deep, the most recent figure standing at $19.3 million for Q4 2017.

  • In Q4 2017, Interest Expenses rose 56.91% year-over-year to $19.3 million; the TTM figure through Sep 2018 stood at $19.3 million (up 19.14% YoY), while the FY2025 annual figure was $20.4 million, up 3.03% from the prior year.
  • Interest Expenses was $19.3 million for Q4 2017 at Edwards Lifesciences, up from $100000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $19.3 million in Q4 2017 to a low of $100000.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 174.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 148.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 96.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2017 19.30 Mn
Dec 31, 2017 19.30 Mn
Sep 30, 2017 100,000.00
Sep 30, 2017 100,000.00
Jun 30, 2017 1.40 Mn
Jun 30, 2017 1.40 Mn
Mar 31, 2017 2.40 Mn
Mar 31, 2017 2.40 Mn
Dec 31, 2016 12.30 Mn
Dec 31, 2016 12.30 Mn
Sep 30, 2016 2.10 Mn
Sep 30, 2016 2.10 Mn
Jun 30, 2016 2.40 Mn
Jun 30, 2016 2.40 Mn
Mar 31, 2016 2.40 Mn
Mar 31, 2016 2.40 Mn
Dec 31, 2010 3.50 Mn
Dec 31, 2010 3.50 Mn
Sep 30, 2010 -400,000.00
Sep 30, 2010 -400,000.00